Details of Drug

Details of Drug

 Drug General Information (ID: D1742)
  Drug Name
Avelumab
  Drug Type Monoclonal antibody
  Drug Synonymous
KXG2PJ551I; 1537032-82-8; Immunoglobulin G1-lambda1, anti-(homo sapiens CD274 (programmed death ligand 1, PDL1, pd-l1, B7 homolog 1, B7H1)), homo sapiens monoclonal antibody; MSB-0010718C; UNII-KXG2PJ551I; Avelumab; Avelumab [USAN:INN]; MSB0010718C
    Click to Show/Hide
  Disease Class 2C30: Melanoma; 2C73: Ovarian cancer; 2A00-2F9Z: Solid tumour/cancer; 2C90: Renal cell carcinoma; 2C34: Neuroendocrine carcinoma
  Therapeutic Class Antineoplastics
  External Link
TTD ID D0K7SX

Drug-Drug Interaction Network
  Sunburst Graph
AM006  Pharmacodynamic additive effects
BM109  Increased risk of other adverse reactions (Unspecific)
  Relation Graph
 Full list of drugs interacting with Avelumab
      Pharmacodynamic additive effects
   Increased risk of other adverse reactions (Unspecific) Drug Num:  3
Drug ID
 
Drug Name
 Formula Pubchem ID Severity Level Interaction Detail REF
D0902
 
Lenalidomide
 
C13H13N3O3
 
216326 
Major    Inter Info   
[1], [2], [3]
D1312
 
Pomalidomide
 
C13H11N3O4
 
134780 
Major    Inter Info   
[1], [2], [3]
D1569
 
Thalidomide
 
C13H10N2O4
 
5426 
Major    Inter Info   
[1], [2], [3]
References
1 Product Information. Pomalyst (pomalidomide). QLT Phototherapeutics Inc, Vancouver, AZ.
2 Product Information. Keytruda (pembrolizumab). Merck &amp Company Inc, Whitehouse Station, NJ.
3 Product Information. Revlimid (lenalidomide). Celgene Corporation, Summit, NJ.